Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket CapitalizationReturn on AssetsReturn on Capital EmployedReturn on Equity

Spyre Therapeutics (SYRE) Asset Utilization Ratio: 2016-2023

Historic Asset Utilization Ratio for Spyre Therapeutics (SYRE) over the last 4 years, with Jun 2023 value amounting to 0.01.

  • Spyre Therapeutics' Asset Utilization Ratio fell 95.53% to 0.01 in Q2 2023 from the same period last year, while for Jun 2023 it was 0.01, marking a year-over-year decrease of 95.53%. This contributed to the annual value of 0.00 for FY2023, which is 83.32% down from last year.
  • Per Spyre Therapeutics' latest filing, its Asset Utilization Ratio stood at 0.01 for Q2 2023, which was down 55.98% from 0.02 recorded in Q1 2023.
  • Over the past 5 years, Spyre Therapeutics' Asset Utilization Ratio peaked at 0.30 during Q1 2022, and registered a low of 0.01 during Q2 2023.
  • For the 3-year period, Spyre Therapeutics' Asset Utilization Ratio averaged around 0.13, with its median value being 0.11 (2021).
  • In the last 5 years, Spyre Therapeutics' Asset Utilization Ratio skyrocketed by 66.03% in 2022 and then plummeted by 95.53% in 2023.
  • Quarterly analysis of 3 years shows Spyre Therapeutics' Asset Utilization Ratio stood at 0.25 in 2021, then tumbled by 88.61% to 0.03 in 2022, then tumbled by 95.53% to 0.01 in 2023.
  • Its Asset Utilization Ratio stands at 0.01 for Q2 2023, versus 0.02 for Q1 2023 and 0.03 for Q4 2022.